Karolinska University Hospital at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Karolinska University Hospital takes part in 3 sessions at ESMO 2026 in Madrid. Its sessions cover bladder and upper gastrointestinal cancers, and expert navigation of grey zones in oncology practice. Highlights include pembrolizumab with or without enfortumab vedotin around surgery for cisplatin-ineligible muscle-invasive bladder cancer, and bispecific T-cell engagers with immune checkpoint inhibitors in upper gastrointestinal cancer.

OrganizationESMO 2026 Attendance
karolinska.se
Cancer centre & hospital
University hospital of the Karolinska Institutet medical university in Stockholm, Sweden.
Abstract
Fri Oct 23
14:22–14:32
Chair
Sat Oct 24
10:15–11:45
Beyond guidelines: Expert navigation through the grey zones of oncology practice
with Fondazione IRCCS Istituto Nazionale dei Tumori
Talk
Mon Oct 26
08:45–09:00
BITE and immune checkpoints
Advancing targeted and immunotherapeutic strategies in upper GI cancer
Gastrointestinal cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Karolinska University Hospital

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction